After receiving his medical degree from the University of Leeds, Dr. Ghani trained in urology in Edinburgh and London. He also has a Master of Surgery thesis from the University of London for research on percutaneous renal stone surgery. Following completion of his sub-specialist training in endourology and stone disease at Guys Hospital, London, he undertook a minimally invasive urologic surgery fellowship at Henry Ford Hospital, Detroit. He joined the University of Michigan faculty in 2013, and oversees the Endourology program at the Ann Arbor VA. Dr. Ghani has authored over 100 peer-reviewed publications and is the editor of Endourology: A Practical Handbook. He is the Course Director of the “Developments in Ureteroscopic Stone Treatment (DUST)” course, which focuses on the Dusting technique for laser stone surgery. Dr. Ghani is also the Co-Director of the Michigan Urological Surgery Improvement Collaborative, statewide consortium of over 40 urology practices focused at improving urological care in the state of Michigan.

Dr. William W. Roberts is a Professor of Urology and Biomedical Engineering at the University of Michigan. He earned a B.S. in Physics from the Massachusetts Institute of Technology in 1992, an M.D. from Johns Hopkins University School of Medicine in 1997, and pursued urology training at the Brady Urological Institute at the Johns Hopkins Hospital. In 2004, he joined the faculty at the University of Michigan, and is now Director of the Division of Endourology. His clinical practice is focused on endourology and stone disease. Dr. Roberts’ research interests include the exploration and translation of histotripsy, a noninvasive, nonthermal, focused ultrasound technology for tissue homogenization that was developed at the University of Michigan. He maintains strong collaborations with colleagues in the Department of Biomedical Engineering to support these efforts. This group was recently awarded the Kennedy Team Excellence Award from the College of Engineering. Dr. Roberts has presented his work at numerous international, national, and regional meetings and has authored over 100 peer-reviewed publications. His research contributions have also been recognized in the form of grants and awards from the National Institutes of Health, American Urological Association, The Engineering and Urology Society, Coulter Foundation, and the Kidney and Urology Foundation of America. He was the 2014 recipient of the prestigious AUA Gold Cystoscope Award.

Endourologist Jodi Antonelli, M.D., is an Assistant Professor in the Department of Urology at UT Southwestern Medical Center. She specializes in the medical and surgical management of kidney stone disease.

Dr. Antonelli earned her medical degree from Jefferson Medical College of Thomas Jefferson University. She completed a general surgery internship and a urology residency at Duke University Medical Center. She completed a fellowship in endourology and stone disease in the Department of Urology at UT Southwestern.

Her research interests include studying metabolic risk factors for kidney stones, particularly the role played by calcium. She is also collaborating with engineers from University of Texas to enhance the surgical instruments used for stone removal.

Dr. Antonelli is a member of the American Urological Association, the Endourological Society, and Alpha Omega Alpha Honor Medical Society.

Dr. Thomas Chi, MD, graduated as a President’s Scholar from Stanford University with a Bachelor of Arts in Human Biology as well as Masters degrees in both Sociology and Music. He went on to earn his medical degree from the University of California, San Francisco School of Medicine. After graduating, he completed two years of general surgery residency training and then a urology residency at UCSF. After completing his Chief Resident year in the Department of Urology, he continued on to finish a fellowship in Endourology and Laparoscopy under the mentorship of Dr. Marshall L. Stoller.

During his fellowship, Dr. Chi was awarded grant funding from the National Institutes of Health and the American Urological Association Urology Care Foundation to research the fundamental mechanisms underlying the formation of urinary stones. During that time he developed a novel model for the study of kidney stones utilizing the common fruit fly, Drosophila melanogaster.

He joined the UCSF faculty of the Department of Urology in 2013 where his clinical interests include the care of patients with urinary stone disease, benign prostatic hypertrophy (BPH) and those in need of minimally invasive surgery. He specializes in the performance of endoscopic, laparoscopic, and percutaneous surgeries. Dr. Chi has used ultrasound guidance to create innovative radiation-free kidney stone surgeries for stone removal, representing the first program of its kind in the United States. He is also experienced in performing Holmium Laser Enucleation of the Prostate (HoLEP) – a minimally invasive operation to treat men with an enlarged prostate. He has established ReSKU, the Registry for Stones of the Kidneys and Ureter, the first kidney stone registry of its kind for tracking patient clinical outcomes and is an internationally recognized specialist in the use of ultrasound in the management of kidney stones to minimize patient radiation exposure.

In addition to his clinical interests, Dr. Chi supervises an NIH-funded translational science lab (click hereto be directed to Dr. Chi’s lab website) where he leads a cross-disciplinary research team. His research focuses on understanding the genetic and microbial environment of the kidney related to how kidney stones form and developing new medical preventative interventions. He has published over 50 peer-reviewed articles and book chapters spanning both basic science as well as epidemiologic approaches centered around improving the care of patients with urinary stone disease.

Dr. Dauw received his medical degree from Loyola University in Chicago graduating Magna Cum Laude. He then completed a urology residency at The University of Michigan. Following this, he pursued subspecialty training in endourology with Dr. James Lingeman at Methodist Hospital in Indianapolis. His primary clinical interests include the medical and surgical management of kidney stones, in particular, endourological management of complex renal calculi. He is also one of few U.S. providers with expertise in holmium laser enucleation of the prostate (HoLEP), a state-of-the-art, minimally invasive surgical treatment for men with an enlarged prostate. His research interests focus on improving the quality of care for patients with kidney stones as well as understanding outcomes associated with commonly performed endourological surgeries.

Dr. Michelle Jo Semins is an Assistant Professor and Urologic Surgeon in the Department of Urology and Director of the Kidney Stone Clinic at Mercy Hospital. She received her undergraduate degree from The University of Michigan and her medical degree from the University of Pittsburgh School of Medicine. She then completed her internship in surgery and residency urology training at Johns Hopkins Hospital with additional specialty training in the field of endourology. Dr. Semins is a current board member of the Northeastern Section of the AUA, and is a member of the American Urological Association, Society of Endourology, the Pittsburgh Urological Society, Research on Calculus Kinetics Society, and the Society of Women in Urology. She has a clinical research focus in kidney stones and is a past awardee of a Young Investigator Research Grant by the Northeastern Section of the AUA. She was also named the Young Urologist of the Year by the AUA in 2016. Dr. Semins is a reviewer for the Journal of Urology and many other peer-review journals. She is a published author of over 40 articles, over 50 abstracts, and 9 book chapters.

Dr. Ojas Shah is a nationally and internationally recognized expert in the medical and surgical management of patients with urinary stone disease. He serves as the Director of the Division of Endourology and Stone Disease at Columbia University Irving Medical Center in New York as well as  the Director of the Fellowship in Endourology.  He is the principal investigator of many clinical research trials regarding the surgical or medical management of stone disease.  Dr. Shah is a member of the American Board of Urology Examination Committee and served on the AUA Guidelines Committee for the Surgical Management of Stone Disease.  He also recently completed his term as Assistant Editor for the Journal of Urology and is co-editor of the textbook Taneja’s Complications of Urologic Surgery.

Dr. Shah is a graduate of the Honors Program in Medical Education at Northwestern University School of Medicine. He completed his urologic training at New York University Medical Center. He spent an additional year at Wake Forest University Health Sciences Center as a fellow in endourology, laparoscopy and metabolic stone disease.

Dr. Teichman specializes in endourology and interstitial cystitis. His primary interests in endourology relate to kidney stones and laser-stone interactions. Ongoing research has focused on understanding the performance characteristics of optical fibers used for holmium:YAG lithotripsy, and the development of improved optical fibers; parameters of mid-infrared lasers for optimal stone fragmentation; the potential application of femtosecond laser ablation. He has current projects on the basic science of laser lithotripsy in collaboration with biomedical optics researchers at the University of Texas, Austin, and laser fiber testing in collaboration with urologists at the Ohio State University, Columbus. His primary interests in interstitial cystitis relate to clinical diagnosis and presentation of patients, often diagnosed after years of symptoms and multiple misdiagnoses. Recent publications have included the interstitial cystitis and dyspareunia, intravesical medication treatment for interstitial cystitis, and the impact of sex abuse on interstitial cystitis. Dr. Teichman is participating in a multicenter trial for a novel urine diagnostic test for interstitial cystitis.

Stuart Wolf is associate chair of clinical integration and operations and professor for the Department of Surgery and Perioperative Care. After receiving his M.D. from Northwestern University, Wolf completed urology residency at UCSF and then an endourology/laparoscopy fellowship with Ralph Clayman. He joined the University of Michigan in 1996 and over the ensuing 20 years he served as the director of the Division of Endourology, the director of the endourology/laparoscopy fellowship and the associate urology department chair for surgical services. In 2016, he assumed his current role as associate chair for clinical integration and operations of the Department of Surgery and Perioperative Care at Dell Medical School. Wolf has served on the executive committee of the Michigan Urologic Society and the board of directors of the Endourological Society. He formerly chaired the AUA Practice Guidelines Committee and is the inaugural chair of the AUA Science and Quality Council. At the University of Michigan, Wolf received the Silver Cystoscope Award for Urology Residency Teaching Excellence three times (1999, 2002 and 2005). He was appointed the inaugural David A. Bloom Professor of Urology in 2006. The Department of Urology awarded him the Faculty Service Award in 2011 and the Outstanding Achievement Award in 2012. He was inducted into the League of Educational Excellence of the University of Michigan Medical School in 2015 and that year he received the Program Director’s Award from the Endourological Society. In 2010, Wolf was elected to the American Association of Genitourinary Surgeons. In 2018, he started a six-year term as a trustee of the American Board of Urology. Early in Wolf’s career, he garnered extramural funding for basic science research but then his interests moved to clinic research. His most recent work focuses on urinary calculi, kidney cancer, upper urinary tract obstruction and a variety or quality improvement and patient safety topics. An author of more than 300 peer-reviewed articles and videos, and more than 150 invited publications, Wolf has served on the editorial boards of 11 journals. His scholarly work has been recognized by awards and/or research grants from the American Foundation for Urologic Disease, the Department of Veterans Affairs, the Endourological Society, the American Society of Transplant Surgeons, and the AUA and 2 of its Sections. He is currently ranked number 84 in the field of Urology (all-time) on the Microsoft Academic Author Analytics website.